Insights

Market Trend Opportunity Grifols' focus on plasma-based therapies aligns with the growing market demand for innovative biopharmaceuticals, presenting a strong sales opportunity in the expanding healthcare sector.

Competitive Positioning Advantage Recent news of the potential buyout offers indicates that Grifols' real value is perceived to be higher than initial offers, highlighting a competitive advantage that can be leveraged to negotiate favorable partnerships and contracts.

Financial Health Strength Despite recent stock price fluctuations, Grifols' rejection of undervalued buyout offers underlines confidence in its long-term prospects, making it an attractive partner for investments and collaborations.

Global Expansion Potential With a workforce in over 30 countries, Grifols has a strong global presence that can be capitalized on to expand its market reach and explore new sales territories, especially in regions where it already operates.

Innovation Sales Drive Being recognized as one of the 'World's Best Companies' and 'Best Employers for Women' showcases Grifols' commitment to excellence and inclusivity, enhancing its reputation and sales potential by attracting partners who value ethical leadership and innovation.

Similar companies to Grifols

Grifols Tech Stack

Grifols uses 8 technology products and services including Exhibit, Lodash, Amazon ALB, and more. Explore Grifols's tech stack below.

  • Exhibit
    Javascript Graphics
  • Lodash
    Javascript Libraries
  • Amazon ALB
    Load Balancers
  • IBM
    Miscellaneous
  • Cisco
    Network Hardware
  • DHL
    Transportation And Fleet Management
  • Adobe Creative Suite
    Visualisation Software
  • Twitter
    Widgets

Media & News

Grifols's Email Address Formats

Grifols uses at least 1 format(s):
Grifols Email FormatsExamplePercentage
First.Last@grifols.comJohn.Doe@grifols.com
92%
FirstL@grifols.comJohnD@grifols.com
3%
First.Middle@grifols.comJohn.Michael@grifols.com
4%
Last.F@grifols.comDoe.J@grifols.com
1%

Frequently Asked Questions

Where is Grifols's headquarters located?

Minus sign iconPlus sign icon
Grifols's main headquarters is located at Parc Empresarial Can Sant Joan Av. de la Generalitat, 152-158 Sant Cugat del Vallès, Barcelona 08174 ES. The company has employees across 6 continents, including North AmericaEuropeSouth America.

What is Grifols's phone number?

Minus sign iconPlus sign icon
You can contact Grifols's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Grifols's stock symbol?

Minus sign iconPlus sign icon
Grifols is a publicly traded company; the company's stock symbol is GRFS.

What is Grifols's official website and social media links?

Minus sign iconPlus sign icon
Grifols's official website is grifols.com and has social profiles on LinkedIn.

How much revenue does Grifols generate?

Minus sign iconPlus sign icon
As of November 2024, Grifols's annual revenue reached $501B.

What is Grifols's NAICS code?

Minus sign iconPlus sign icon
Grifols's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Grifols have currently?

Minus sign iconPlus sign icon
As of November 2024, Grifols has approximately 11K employees across 6 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: N. A.Chief Executive Officer: A. F.Chief Executive Officer: M. G.. Explore Grifols's employee directory with LeadIQ.

What industry does Grifols belong to?

Minus sign iconPlus sign icon
Grifols operates in the Pharmaceutical Manufacturing industry.

What technology does Grifols use?

Minus sign iconPlus sign icon
Grifols's tech stack includes ExhibitLodashAmazon ALBIBMCiscoDHLAdobe Creative SuiteTwitter.

What is Grifols's email format?

Minus sign iconPlus sign icon
Grifols's email format typically follows the pattern of . Find more Grifols email formats with LeadIQ.

How much funding has Grifols raised to date?

Minus sign iconPlus sign icon
As of November 2024, Grifols has raised $326M in funding. The last funding round occurred on Jun 04, 2024 for $326M.

When was Grifols founded?

Minus sign iconPlus sign icon
Grifols was founded in 1909.
Grifols

Grifols

Pharmaceutical ManufacturingBarcelona, Spain10001+ Employees

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. 

A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. 

Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. 

Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases.

With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth.

People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers.

In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all.

To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Section iconCompany Overview

Headquarters
Parc Empresarial Can Sant Joan Av. de la Generalitat, 152-158 Sant Cugat del Vallès, Barcelona 08174 ES
Phone number
Stock Symbol
GRFS
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1909
Employees
10001+

Section iconFunding & Financials

  • $326M

    Grifols has raised a total of $326M of funding over 2 rounds. Their latest funding round was raised on Jun 04, 2024 in the amount of $326M.

  • $1B

    Grifols's revenue is in the range of $1B

Section iconFunding & Financials

  • $326M

    Grifols has raised a total of $326M of funding over 2 rounds. Their latest funding round was raised on Jun 04, 2024 in the amount of $326M.

  • $1B

    Grifols's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.